Details for New Drug Application (NDA): 061325
✉ Email this page to a colleague
NDA 061325 describes NILSTAT, which is a drug marketed by Lederle, Strides Pharma, and Chartwell Molecules, and is included in six NDAs. It is available from one supplier. Additional details are available on the NILSTAT profile page.
The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Medical Subject Heading (MeSH) Categories for 061325
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | 100,000 UNITS | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
